ID: ALA5175372

Max Phase: Preclinical

Molecular Formula: C11H9NO3

Molecular Weight: 203.20

Associated Items:

Representations

Canonical SMILES:  COCc1nc2ccc3occc3c2o1

Standard InChI:  InChI=1S/C11H9NO3/c1-13-6-10-12-8-2-3-9-7(4-5-14-9)11(8)15-10/h2-5H,6H2,1H3

Standard InChI Key:  IJMMUNGKBIHKTG-UHFFFAOYSA-N

Associated Targets(non-human)

Seed lipoxygenase-1 463 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 203.20Molecular Weight (Monoisotopic): 203.0582AlogP: 2.72#Rotatable Bonds: 2
Polar Surface Area: 48.40Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.43CX LogD: 1.43
Aromatic Rings: 3Heavy Atoms: 15QED Weighted: 0.64Np Likeness Score: -0.06

References

1. Neha K, Wakode S..  (2021)  Contemporary advances of cyclic molecules proposed for inflammation.,  221  [PMID:34029774] [10.1016/j.ejmech.2021.113493]

Source